Icodextrin: A major problem for glucose dehydrogenase-based glucose point of care testing systems

Acta Clinica Belgica

Volumn 61, Issue 6, 2006, Pages 351-354

  Flore K ^b   Delanghe, J ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

Amylase; Continuous ambulatory peritoneal dialysis (CAPD); Glucose dehydrogenase; Icodextrin; Point of care testing (POCT)

Indexed keywords

GLUCOSE; GLUCOSE DEHYDROGENASE; ICODEXTRIN; INSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DEPOLYMERIZATION; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; POINT OF CARE TESTING;

EID: 33846947575     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2006.055     Document Type: Article

References (11)

1. Woodrow g, stables G, Oldroyd B, Gibson J, Turney J, Brownjohn A. Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis. Nephrol Dial Transplant 1999; 14: 1530-5.
2. Riley SG, Chess J, Donovan KL, Williams JD. Spurious hyperglycaemia and icodextrin in peritoneal dialysis fluid. BMJ 2003; 327:608-9.
3. D'Orazio P, Burnett RW, Fogh-Ansersen N et al. The international Federation of Clinical Chemistry Scientific Division Working Group on Selective Electrodes and Point of Care Testing. Approved IFCC Recommendation on Reporting Results for blood glucose (Abbreviated). Clin Chem 2005; 51: 1573-6.
4. Janssen W, Harff G, Caers M, Schellekens A. Positive interference of icodextrin metabolites in some enzymatic glucose methods. Clin Chem 1998; 44: 2379-80.
5. Apperloo JJ, Vader HL . A quantitative appraisal of interference by icodextrin metabolites in point-of-care glucose analyses. Clin Chem Lab Med 2005; 43: 314-8.
6. Wens R, Taminne M, Devriendt J, Collart F, Broeders N, Mestrez F, Germanos H, Dratwa M. A previously undescribed side effect of icodextrin: overestimation of glycemia by glucose analyzer previously undescribed side effect of icodextrin: overestimation of glycemia by glucose analyzer. Perit Dial Int 1998 ;18: 603-9.
7. Apperloo JJ, Vader HL . A quantitative appraisal of interference by icodextrin metabolites in point-of-care glucose analyses. Ned Tijdschr Klin Chem Labgeneesk 2005; 30-83.
8. nd ed, AACC Press 1989; 3-29.
9. Buis B, Koomen GC, Imholz AL, et al. Effect of electric charge on the transperitoneal transport of plasma proteins during CAPD. Nephrol Dial Transplant 1996;11:1113-20.
10. Wang R, Leesch V, Turner P, Moberly JB, Martis L Kinetic analysis of icodextrin interference with serum amylase assays. Adv Perit Dial 2002;18:96-9.
11. Fox RE, Redstone D. Sources of error in glucose determinations in neonatal blood by glucose oxidase methods, including Dextrostix. Am J Clin Pathol 1976; 66:658-66.